Search Results
Showing 1 of 1 search results for:
A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
Status
Condition
Systemic Lupus Erythematosus
Phase
INTERVENTION
Drug: CC-220, Drug: CC-220, Drug: CC-220, Drug: CC-220, Drug: Placebo
Eligibility
Ages Eligible for Study : 18 Years and older (Adult, Older Adult)
Sexes Eligible for Study : All
Accepts Healthy Volunteers : No
Result 1 of 1